Sean Lee
Stock Analyst at HC Wainwright & Co.
(5)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AKTX Akari Therapeutics | Reiterates: Buy | 2 2 | 0.77 | 107.79% | 2 | Sep 9, 2025 | |
CASI CASI Pharmaceuticals | Reiterates: Buy | 4 4 | 2.33 | 71.67% | 10 | Sep 3, 2025 | |
NVAX Novavax | Assumes: Buy | 10 | 8.28 | 20.77% | 1 | Aug 28, 2025 | |
MYO Myomo | Maintains: Buy | 10 5 | 0.89 | 461.8% | 6 | Aug 12, 2025 | |
KZIA Kazia Therapeutics | Maintains: Strong Buy | 2 13 | 8.15 | 59.51% | 5 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 2 2 | n/a | n/a | 2 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 3 | n/a | n/a | 12 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1 1 | 0.95 | 5.26% | 13 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 10 14 | 9.35 | 49.73% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 10 | 4.9 | 104.08% | 1 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 20 | 15.63 | 27.96% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 40 | 47.66 | -16.07% | 10 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 11 11 | 6.06 | 81.52% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 5 | n/a | n/a | 4 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 1 | n/a | n/a | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Mar 19, 2021 |